Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/- cetuximab in oesophageal cancer.

Crosby, T; Hurt, C N; Falk, S; Gollins, S; Staffurth, J; Ray, R; Bridgewater, J A; Geh, J I; Cunningham, D; Blazeby, J; Roy, R; Maughan, T; Griffiths, G; Mukherjee, S

Crosby, T; Hurt, C N; Falk, S; Gollins, S; Staffurth, J; Ray, R; Bridgewater, J A; Geh, J I; Cunningham, D; Blazeby, J; Roy, R; Maughan, T; Griffiths, G; Mukherjee, S.

Affiliation

Crosby T; Velindre Cancer Centre, Velindre Hospital, Cardiff CF14 2TL, UK.
Hurt CN; Wales Cancer Trials Unit, Cardiff University, Cardiff CF14 4YS, UK.
Falk S; Bristol Haematology and Oncology Centre, University Hospitals Bristol NHS Foundation Trust, Bristol BS2 8ED, UK.
Gollins S; North Wales Cancer Treatment Centre, Conwy and Denbighshire NHS Trust, Rhyl LL18 5UJ, UK.
Staffurth J; Velindre Cancer Centre, Velindre Hospital, Cardiff CF14 2TL, UK.
Ray R; Wales Cancer Trials Unit, Cardiff University, Cardiff CF14 4YS, UK.
Bridgewater JA; UCL Cancer Institute, University College London, London WC1E 6BT, UK.
Geh JI; Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust Birmingham B15 2GW, UK.
Cunningham D; The Royal Marsden Hospital NHS Foundation Trust, London SM2 5PT, UK.
Blazeby J; Centre for Surgical Research, University of Bristol, Bristol BS8 2PS, UK.
Roy R; Diana Princess of Wales Hospital, Northern Lincolnshire and Goole NHS Foundation Trust, Grimsby DN33 2BA, UK.
Maughan T; CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford OX3 7DQ, UK.
Griffiths G; Southampton Clinical Trials Unit, University of Southampton, Southampton SO16 6YD, UK.
Mukherjee S; CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford OX3 7DQ, UK.

Br J Cancer ; 116(6): 709-716, 2017 Mar 14.

Article in En | MEDLINE | ID: mdl-28196063

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Carcinoma, Squamous Cell / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols / Chemoradiotherapy / Neoplasm Recurrence, Local Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male Language: En Journal: Br J Cancer Year: 2017 Document type: Article Affiliation country: Reino Unido Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google